Zimmer Biomet announced a limited distribution agreement with THINK Surgical regarding its wireless, handheld, TMINI Miniature Robotic System for total knee arthroplasty. The agreement will result in an exclusive offering, integrating Zimmer Biomet technology into a customized TMINI robotic solution. The TMINI system complements Zimmer Biomet’s flagship ROSA Robotics portfolio with a handheld robotic option that enables accurate implant placement to a predetermined CT-based, three-dimensional surgical plan. Zimmer Biomet anticipates introducing the customized TMINI System to select markets in the U.S. in the second half of 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet price target lowered to $125 from $130 at Barclays
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Zimmer Biomet initiated with a Neutral at Goldman Sachs
- Zimmer Biomet formalizes partnership with CBRE
- Zimmer Biomet board approves new stock buyback authorization for up to $2B